Work on building the future of generative AI drug discovery. Absci is looking for a Senior R&D Program Manager to play a key role in advancing our innovative pipeline programs. Join us in our mission to create better biologics for patients, faster. Apply now: https://lnkd.in/g6x39PsS #Hiring #ProgramManagement #AI #Biologics #DrugDiscovery
关于我们
Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.
- 网站
-
https://www.absci.com
Absci的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Vancouver,Washington
- 类型
- 上市公司
- 创立
- 2011
- 领域
- generative AI、synthetic biology、biologics、drug discovery、antibody development、artificial intelligence、pharmaceuticals和biotechnology
地点
-
主要
US,Washington,Vancouver,98683
Absci员工
动态
-
Don’t miss our presentation “Next-Gen Hair Growth: AI & Antibody Optimization Targeting PRLR”? tomorrow at 3:35 PM ET. Find the full conference schedule here: https://lnkd.in/g-CftAGu #AI #Biologics #DrugDiscovery
Join Absci’s Head of Translational Research Amer-Denis Akkad's presentation at the Dermatology Innovation Forum 2025 in Orlando, Florida on March 6. Learn how we leveraged our generative AI platform to design ABS-201, a novel anti-prolactin receptor antibody for the potential treatment of androgenic alopecia, a disease that affects over 80M Americans.? Our AI models engineered improved properties in vivo including: high-affinity and potency, extended half-life, and an excellent developability profile to create a potentially category-defining treatment for androgenic alopecia. ? Learn more here: https://lnkd.in/gy5Wvim4 #AI #Biologics #DrugDiscovery
-
-
Absci Founder & CEO Sean McClain will be joining AMD CTO Mark Papermaster for a fireside chat tomorrow to discuss how we are working together to scale AI-driven innovation in the life sciences industry at The University of Texas at Austin's Life Science and Healthcare Innovation Summit. Learn more here: https://lnkd.in/g_Q98zbs #AI #Biologics #DrugDiscovery
-
-
Absci转发了
Join Absci management for a fireside chat at TD Cowen’s 45th Annual Health Care conference next Monday, March 3rd at 3:10 PM EST. Watch the presentation live or find an archived copy on our investor site here: https://lnkd.in/gXQA4qW7 #AI #Biologics #DrugDiscovery
-
-
Absci转发了
???Transforming healthcare. Hear from Absci founder and CEO Sean McClain on how this innovative generative AI drug creation company?is getting?better biologics?to?patients, faster.
-
Absci Founder & CEO Sean McClain and SVP of Drug Creation Christian M. Stegmann, PhD MBA, recently sat down with Bloomberg’s 'Vanguards of Health Care' podcast to discuss Absci's generative AI platform and how our tech stack has the potential to transform drug discovery and bring differentiated medicines to patients. Listen to it here:? https://lnkd.in/gWX4qviq #AI #Biologics #DrugDiscovery
-
Join Absci management for a fireside chat at TD Cowen’s 45th Annual Health Care conference next Monday, March 3rd at 3:10 PM EST. Watch the presentation live or find an archived copy on our investor site here: https://lnkd.in/gXQA4qW7 #AI #Biologics #DrugDiscovery
-
-
We are excited to welcome Michael Mangone as VP, Business Development! Help us give Mike a warm welcome with a like or a comment below!?? #AI #Biologics #DrugDiscovery
-
-
Join Absci’s Head of Translational Research Amer-Denis Akkad's presentation at the Dermatology Innovation Forum 2025 in Orlando, Florida on March 6. Learn how we leveraged our generative AI platform to design ABS-201, a novel anti-prolactin receptor antibody for the potential treatment of androgenic alopecia, a disease that affects over 80M Americans.? Our AI models engineered improved properties in vivo including: high-affinity and potency, extended half-life, and an excellent developability profile to create a potentially category-defining treatment for androgenic alopecia. ? Learn more here: https://lnkd.in/gy5Wvim4 #AI #Biologics #DrugDiscovery
-
-
Absci转发了
You can hear in this short clip just how excited AMD is about the collaboration and investment in Absci. Together, we will tackle one of the hardest problems on earth—drug discovery—through the transformative power of generative AI and advanced computing. Absci is deploying AMD Instinct accelerators and ROCm software. By optimizing AI solutions, they will benefit from exceptional performance, reduced infrastructure costs, and faster innovation cycles. Watch the full discussion I have with Absci Founder and CEO Sean McClain to learn more. https://lnkd.in/gZCGGM4R